Abstract
Malaria is a life-threatening disease which has caused enormous public health challenge. A mathematical model describing the dynamics of malaria between the human and vector population is formulated to understand the important parameters in the transmission and develop effective prevention and control strategies. We analysed the model and found that the model has a disease-free equilibrium (DFE) which is locally and globally asymptotically stable if the effective reproduction number can be brought below unity. Our model shows that the infectivity of mildly infected children and adults amplifies the disease burden in a population. It was shown that the model does not undergo the phenomenon of backward bifurcation so long as the recovered children and adults do not lose their acquired immunity and if the infection of mildly infected adult is not high enough to infect susceptible mosquitoes. However, control strategies involving mosquito reduction through high rate of application of insecticide will serve as an effective malaria control strategy. It is further shown that whenever the effective reproduction number is greater than unity the model has a unique endemic equilibrium which is globally stable for the case when there is loss of acquired immunity in children and adults. Numerical simulations show that the presence of all the control strategies is more effective in preventing mild malaria cases in adult and children as compared to severe malaria cases in adult and children.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Self funded
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The British Community Hospital and Outpatient Clinic, Ipaja, Lagos. EBIHAS Virtual Research and Training LTD
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Details on data source are included in the manuscripts. Sources are properly referenced.
